YouTubeFacebookLinkedInTwitterinstagramrss

Browse Top Headlines

Search Text
Start Date
End Date

Follow the Money: Cash for AI Models, Oncology, Hematology Therapies

TODAY | Bio-IT World  Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. Glioblastoma, hematology, and acute pancreatitis all see new funding for therapy development. And AI-powered models net cash.

Ancestry Launches NGS Tests With Family History Component

|

Bio-IT World | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.

One Small Step For Open Science, One Giant Leap For Metastasis Research

|

Bio-IT World | In a first-of-its-kind collaboration, researchers from 19 academically affiliated international laboratories have agreed to share their cell line models specific to brain metastasis with pretty much anyone who asks for them.

New Data on Genetic Expression In Severe COVID-19, Pre-Existing Immune Response

|

Bio-IT World | Research continues to uncover the underlying biology of SARS-CoV-2 and reveal some surprises. A German team found that 35% of their healthy controls had pre-existing SARS-CoV-2 cross-reactive T cells, and several groups are narrowing down the gene expression signatures that might explain why COVID-19 is so severe in some patients.

Celsius Therapeutics, Twist Bioscience, And More: News From July 2020

|

Bio-IT World July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Celsius Therapeutics, Twist Bioscience, and more.

Coronavirus Exposure Could Induce Long-Lasting Memory T Cells, Other COVID-19 News

|

Bio-IT World | A new collaborative study suggests that infection and exposure to coronaviruses induces long-lasting memory T cells, which could help in the management of the current pandemic and in vaccine development against COVID-19. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

Cell, Gene Therapy Manufacturing As Large-Scale Biology

|

Bio-IT World Contributed Commentary | The last three years we have witnessed an exponential expansion of the cell and gene therapy space, both in the number of cell and gene therapies approved or in development, and the real and projected values of the market. This growth is rapidly changing the way we think about what medicines are.

PacBio’s Focus on Human Genomics And Read Length Sweet Spot

|

Bio-IT World | It seems like a very long time ago, now, that Illumina and Pacific Biosciences dissolved their merger agreement, but in fact their announcement is just about six months old. Since then, PacBio has been busy reestablishing itself as an independent business and looking ahead, their sights set on the human genome sequencing market.

How Mass Spectrometry is Accelerating Quantitative Proteomics

|

Bio-IT World Contributed Commentary | Mass spectrometry has transitioned from being used mostly in routine analytical applications to becoming a powerful biological method for protein quantitation.

Populations With Unique Enzymes More Susceptible To COVID-19, Other News

|

Bio-IT World | Researchers from Cleveland Clinic have found unique genetic susceptibility to COVID-19 across populations in ACE2 and TMPRSS2. Elsewhere, the University of California Health has developed a unified, secure data set for use in COVID-19 research. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age

|

Bio-IT World | Duplex Sequencing, a technique for improving the accuracy of next-generation sequencing by more than 10,000-fold, could eliminate a good deal of the guesswork in advancing drugs to market.

Breaking Silos to Enable Breakthroughs

|

Bio-IT World | TRENDS FROM THE TRENCHES | For most big pharma and other global enterprises, decades of growth have resulted in siloed operations, even as they seek breakthrough medicines. It is time for such a breakthrough; as an industry, we’re overdue.

Illumina Launches TruSight Software Suite, Accelerating Identification of Genetic Diseases

|

Bio-IT World News Brief | Illumina, in collaboration with Mayo Clinic and other key opinion leaders, has launched its TruSight Software Suite in an effort to bring turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing.

Study Says Prior Infection Could Prevent Reinfection, Other COVID-19 News

|

Bio-IT World | Animal models are showing how prior infection of the SARS-CoV-2 virus can provide protection against reinfection. Elsewhere, a coronavirus task force task force is examining genes associated with COVID-19 immune response by collecting samples from Japanese patients. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.

Virtual Twins: Their Roles In Healthcare, Drug Discovery, And Pandemic Response

|

Bio-IT World | In a world that has shifted to virtual everything—work, recreation, connection—it’s no wonder that virtual or digital twins are getting more attention. It’s certainly a favorite term of marketers: we are creating digital twins for everything from people to businesses, instruments to labs.

Can Your Data Protection Strategy Survive A Pandemic?

|

Bio-IT World Contributed Commentary | Across the world, scientific laboratories have redirected their research efforts toward the global COVID-19 pandemic. Achieving the goal of understanding and treating the virus requires the generating and gathering of data. Like any big shift in the way we generate, manage, or use data, this will have implications for the datacenter.

Bio-IT World Announces 2020 Innovative Practices Award Winners

|

Bio-IT World | Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance have been announced as the winners of the 2020 Innovative Practices Awards.

How The SARS-CoV-19 Virus Attacks Cells, Other COVID-19 News

|

Bio-IT World | New research shows how the SARS-CoV-19 virus shifts the cell's activity to promote its own replication and to infect nearby cells. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.

Saving Lives with Great Research Requires a Research Tech Rethink

|

Bio-IT World Contributed Commentary | Researchers are working hard to provide the evidence needed for fact-based decisions addressing everything from developing new vaccines, to ensuring existing treatments are being used to their best advantage. Now, more than ever, the time and funding allocated for these projects must be used to their fullest extent.

Bringing Light—and Value—to Dark Data in Research & Design

|

Bio-IT World Contributed Commentary | Data are often recognized as a top asset of organizations in any field, including the biosciences, but the way it’s handled may not adequately reflect this. One explanation for this mismatch is that the amount of data being produced every day is enormous—but not necessarily accessible.

 1